Table 2.
Summary of single-cell isolation protocols for cartilage in reported studies using scRNA-seq technique
| Reference | Tissue | Species | Treatment | Number of profiling cells |
|---|---|---|---|---|
| Quanbo Ji, et al. [34] | Cartilage from 10 knee OA patients | Human | 0.25% Trypsin–EDTA for 30 min and then 0.2% type II collagenase (Sigma-Aldrich) for 4 h | 1600 |
| Fiorella Carla Grandi, et al. [35] | OA samples from patients undergoing total joint replacement | Human | Collagenase II and IV (2.5 mg/ml each; Worthington Biochem) overnight | Not reported |
| Junxiang Li, et al. [36] | The distal cartilage structure at postnatal day 7 | Mouse | 0.2% collagenase II for 2 h | 217 |
| Vikram Sunkara, et al. [37] | Femur of 12 weeks old mice | Mouse | 10 mg/ml Collagenase II (Nordmark) supplemented for 4 h | 7133 |
| Koji Mizuhashi, et al. [38] | Femur growth plate cells at postnatal day 2 | Mouse | Liberase TM (Sigma/Roche) for unclear time | 18,000 |
| Natalie H Kelly, et al. [39] | Hindlimb bud of embryonic mice | Mouse | Collagenase Type II (Worthington-biochem, Lakewood, NJ) and pronase (EMD Millipore, Billerica, MA) in 15 min increments with agitation for up to 1 h | 9466 |